CONMED Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 1,244.74 million compared to USD 1,045.47 million a year ago. Net income was USD 64.46 million compared to net loss of USD 80.58 million a year ago.

Basic earnings per share from continuing operations was USD 2.1 compared to basic loss per share from continuing operations of USD 2.68 a year ago. Diluted earnings per share from continuing operations was USD 2.04 compared to diluted loss per share from continuing operations of USD 2.68 a year ago.